Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100163 · ClinicalTrials.gov registry record · NA
Virtual Reality Pain Control Orthopedic Trauma
A NA study, sponsored by National Institute of General Medical Sciences (NIGMS).
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT02100163: Completed NA study, sponsored by National Institute of General Medical Sciences (NIGMS).
NCT02100163 is a NA study that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 211 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02100163, a NA study, has completed, sponsored by National Institute of General Medical Sciences (NIGMS).
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
The treatment of postoperative pain after severe trauma is poorly understood, and it can lead to chronic pain, opiate drug addiction and elevated health care costs. The proposed project will be a randomized controlled trial to evaluate an innovative methodology for delivering clinical hypnosis (virtual reality hypnosis) for pain control as well as a more time-honored delivery system that uses audio recordings. The goal will be to reduce postoperative pain in a sample of patients hospitalized for the care of severe orthopedic trauma and other types trauma. This proposal will test innovative and low-risk approaches to reducing postoperative trauma pain that are designed to reduce pain, anxiety and other complications after surgery. The findings have the potential not only to reduce pain and suffering in patients who have suffered severe trauma but could be applicable to the millions of people who have surgery every year. Reducing addictive opiate-based medication and health care costs are both potential outcomes from this project.
Primary Outcome
Measures pain and anxiety
Interventions
- OTHER Standard treatment
- BEHAVIORAL Virtual Reality Hypnosis
- BEHAVIORAL Audio Hypnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-06-24 |
| Phase | NA |
What the finished NCT02100163 record still lists
NCT02100163 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard treatment is the first listed.
NCT02100163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02100163 about?
NCT02100163 is a clinical study titled "Virtual Reality Pain Control Orthopedic Trauma". The treatment of postoperative pain after severe trauma is poorly understood, and it can lead to chronic pain, opiate drug addiction and elevated health care costs. The proposed project will be a randomized controlled trial to evaluate an innovative methodology for delivering clinical hypnosis (virt...
What is the current status of trial NCT02100163?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2014-03. Estimated completion is 2018-06-24.
What interventions are being tested in trial NCT02100163?
The interventions under investigation include: Standard treatment (OTHER), Virtual Reality Hypnosis (BEHAVIORAL), Audio Hypnosis (BEHAVIORAL).
Who is sponsoring clinical trial NCT02100163?
This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02100163's enrollment target sits among peer trials
211 490th of 2000 higher than 1,511 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia